ASCO Announces CancerLinQ Partnerships With the FDA and the NCI

June 2, 2017 – CancerLinQ®, ASCO’s big data initiative to rapidly improve the quality of cancer care, is partnering with the U.S. Food and Drug Administration (FDA) and the National Cancer Institute (NCI) to study the real-world use of newly approved cancer treatments and speed and strengthen the collection of national cancer surveillance data to improve patient care. The announcement was made at the 2017 ASCO Annual Meeting in Chicago. The goal of .. (leggi tutto)